An Expert’s Guide to ASH 2024: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Key Insights on CD38 and BCMA as Targets for Therapy in Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Targeting CD38 and BCMA in Myeloma: Evidence and Enhanced Outcomes With Innovative Therapies

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Antibody–Drug Conjugates, Bispecific Antibodies and CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--
Critical Actions in Emergency Medicine: Timely Diagnosis and Treatment of CAR T-Cell‒ and Bispecific Antibody‒Related AEs in Multiple Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--
Experts Answer Questions About Therapies Targeting BCMA and SLAMF7 in Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Immuno-Oncology in Myeloma: New Indications and Approvals

Content Format:

Slideset

Credit Type:

--

Credits:

--
An Update in Diagnosis, Prognosis, and Treatment of Multiple Myeloma – for the Treating Oncologist

Content Format:

Slideset

Credit Type:

--

Credits:

--
New Therapeutic Opportunities in Myeloma

Content Format:

Slideset

Credit Type:

--

Credits:

--